1133PDA phase IIa trial to assess the safety and efficacy of BL-8040 and pembrolizumab in patients with metastatic pancreatic adenocarcinoma (PDAC). (23rd October 2018) - Hidalgo, M; Epelbaum, R; Wolpin, B M; Stemmer, S M; Geva, R; Golan, T; Borazanci, E; Borad, M; Pedersen, K S; Park, J O; Ramirez, R; Peled, A; et al.